ArticleCureus2026

Therapeutic Challenges in Metastatic Non-small Cell Lung Cancer (NSCLC) With Concurrent Mesenchymal-Epithelial Transition Factor (MET) Amplification and High Programmed Death-Ligand 1 (PD-L1) Expression: A Case Study.

Md Arifur Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.